Top 10 Medical Equipment Trends in 2009: Industry Report

Top 10 Medical Equipment Trends in 2009

Product Type: Market Research Report
Published by: Global Markets Direct
Published: December 2008
Product Code: R3480-7455

Description

Top 10 Medical Equipment Trends in 2009

Summary

Global Markets Direct’s “Top 10 Medical Equipment Trends in 2009” report an essential source of information and analysis that will help answer questions like: which companies are poised for high growth in the coming few years?, which are the growth sectors?, how are competitors responding to changing market dynamics?, what products are in pipeline and how would they impact sector growth?, which medical equipment sectors would retain investor confidence?, and what are the regulatory trends in leading economies and emerging economies? These are among the many questions that will be answered with insightful analysis in this report. The report analyses the ten major trends expected to influence the future of global medical equipment industry. A strong understanding of the key trends to impact the medical equipment industry will prove to be a decisive factor in strategic planning and decision making for all involved in the value chain - investors, manufacturers, distributors, regulators, payer/providers and analysts tracking this industry.

Scope

The report covers information and analysis on medical equipment markets in North America, Europe, Asia Pacific, South Central America, Middle East and Africa.
The report provides market size data and information on 10 medical equipment markets namely Cardiovascular devices, Orthopedic devices, Diagnostic Imaging, Anesthesia and respiratory devices, Drug delivery devices, ENT devices, Healthcare IT, Hospital supplies, In-vitro diagnostics and Diabetes care devices.
Annualized market revenues data from 2000 to 2007, forecast forward for 5 years to 2012.
Analysis and review of the key events and milestones that will impact the future of medical equipment market globally. Each trend independently researched to provide qualitative analysis of
what the implications on sectors are, and how are companies responding to these trends.
Insightful review of key industry drivers, restraints and challenges which are likely to impact the global medical equipment industry in the long run.
In-depth analysis of the medical equipment M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
Key topics covered include the emergence of Direct to Consumer (DTC) marketing, increasing use of home and self care medical devices, the likely impact of the ongoing credit crunch and the expected landscape post the US presidential elections.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct’s team of industry experts.

Reasons to buy

Develop business strategies by understanding the trends shaping and driving the global medical equipment industry.
Organize your sales and marketing efforts by identifying the prevalent and expected competitive landscape in different medical equipment markets.
Design and develop more effective product development, marketing and sales strategies.
Identify key players who are best positioned to take advantage of the emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
What’s the next being thing in the medical equipment technology landscape? - Identify, understand and capitalize.
Do better by understanding the regulatory scenario in the leading economies. evaluate approval process and reimbursement trends to make your expansion plans more efficient, effective and timely.

Table of Contents

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What is this Report About?; 2.2 Global Markets Direct Report Coverage; 2.3 Definitions
3 Top 10 Medical Equipment Trends in 2009: 3.1 Executive Summary
4 Direct-to-consumer Advertising: Increased adoption to heat the market space: 4.1 Overview; 4.2 The FDA and the US Senate Special Committee on Aging; 4.3 Reasons Companies are adopting DTC Advertising as a marketing strategy; 4.4 DTC Advertising in the Cardiovascular Devices Market; 4.5 DTC Advertising in the Orthopaedic Devices Market; 4.6 DTC Advertising in Optometry; 4.7 Future Outlook
5 Emerging Medical Device Technology Economies: 5.1 Overview; 5.2 Medical Device Technology in China; 5.3 Medical Device Technology in Russian Federation; 5.4 Medical Device Technology in Brazil; 5.5 Medical Device Technology in India; 5.6 Medical Device Technology in Taiwan; 5.7 Medical Device Technology in Republic of Korea; 5.8 Medical Tourism
6 Healthcare IT: Redefining the healthcare delivery and management: 6.1 Overview; 6.2 Impact of Healthcare IT; 6.3 Healthcare Interoperability; 6.4 Telehealth; 6.5 Future Outlook
7 Drug eluting stents: Renewed flow in the US market: 7.1 Overview; 7.2 Is Drug Eluting Stent Safe?; 7.3 Companies to Benefit; 7.4 Future Outlook
8 The US hip resurfacing market: Over-hyped or else?: 8.1 Overview; 8.2 Reasons for Smith & Nephew’s Dominance; 8.3 The US Hip Resurfacing Market Restraints; 8.4 Conclusions
9 The Global Home Healthcare Equipment Market: Poised for robust return: 9.1 Overview; 9.2 Diabetes Care Devices; 9.3 ENT Devices - Hearing Aids; 9.4 Respiratory Devices; 9.5 Drug Delivery Devices; 9.6 Future Outlook
10 Companies to watch out for in 2009: 10.1 Overview; 10.2 Abbott Laboratories; 10.3 Medtronic Corporation; 10.4 Hologic Corporation; 10.5 Small Bone Innovations; 10.6 Getinge AB; 10.7 Integra; 10.8 Edward Lifesciences Corporation; 10.9 Core Essence Orthopedics Inc (Core); 10.10 Alcon - AcrySof ReSTOR Toric IOL; 10.11 Volcano Corporation - IVUS Guided Balloon Catheter; 10.12 AcuFocus Inc - AcuFocus ACI 7000
11 Wall Street financial crisis: What’s in store for the medical equipment industry?: 11.1 A Backgrounder; 11.2 The Medical Equipment Industry Perspective; 11.3 Global Medical Equipment Deal Landscape; 11.4 Impact Analysis; 11.5 Future Outlook
12 Barack Obama as the US President: Medical Equipment Industry perspective: 12.1 Introduction; 12.2 Issues in front of the US Healthcare System; 12.3 Impact of Rising Healthcare costs; 12.4 Barack Obama’s Healthcare Reforms Plan; 12.5 Medical Equipment Industry future in Barack Obama’s reign
13 Medical Equipment M&A Landscape for 2009: 13.1 Overview; 13.2 Acquisitions; 13.3 Future Outlook
14 Appendix: 14.1 Methodology; 14.2 Coverage; 14.3 Secondary Research; 14.4 Primary Research; 14.5 Models; 14.6 Forecasts; 14.7 Expert Panels; 14.8 Contact Us; 14.9 Disclaimer
1.1 List of Tables: Table 1: Major DTC Advertising Campaigns; Table 2: Orthopedic Devices , US, Overall Revenue ($ mn), 2000 - 2012; Table 3: Medical Equipment, China, Overall Revenue ($ mn), 2000 - 2012; Table 4: Medical Equipment, Russian Federation, Overall Revenue ($ mn), 2000-2012; Table 5: Medical Equipment, Brazil, Overall Revenue ($ mn), 2000 - 2012; Table 6: Medical Equipment, India, Overall Revenue ($ mn), 2000 - 2012; Table 7: Medical Equipment, Taiwan, Overall Revenue ($ mn), 2000-2012; Table 8: Medical Equipment, Republic of Korea, Overall Revenue ($ mn), 2000 - 2012; Table 9: Procedure costs , US, UK, India, Thailand, Singapore, ($), 2008; Table 10: Medical Tourism, India, Overall Revenue ($ mn), 2000 - 2012; Table 11: Healthcare IT, Global, Overall Revenue ($ mn), 2000 - 2012; Table 12: Healthcare IT, Revenue Breakup by Geography ($mn), 2007; Table 13: PACS, Global, Overall Revenue ($ mn), 2000 - 2012; Table 14: Hospital Information Systems, Global, Overall Revenue ($ mn), 2000 - 2012; Table 15: Healthcare IT, India, Overall Revenue ($ mn), 2000 - 2012; Table 16: Coronary Stent, US, Overall Revenue ($ mn), 2000 - 2007; Table 17: Drug Eluting Stent, US, Overall Revenue ($ mn), 2007 - 2012; Table 18: Hip Resurfacing, US, Overall Revenue ($ mn), 2006 - 2012; Table 19: Home Healthcare Equipment, Global, Overall Revenue ($ mn), 2007 - 2012; Table 20: Diabetes care devices, Global, Overall Revenue ($ mn), 2000 - 2012; Table 21: Glucose Monitoring and Insulin Delivery devices, Global, Overall Revenue ($ mn), 2000-2012; Table 22: Digital Signal Processing Hearing Aids, Global, Overall Revenue ($ mn), 2000 - 2012; Table 23: CPAP and Nebulizers, Global, Overall Revenue ($ mn), 2000 - 2012; Table 24: Drug Delivery Devices, Global, Overall Revenue ($ mn), 2000 - 2012; Table 25: Dry Powdered Inhalers, Global, Overall Revenue ($ mn), 2000 - 2012; Table 26: Needle Free Injections, Global, Overall Revenue ($ mn), 2007-2012; Table 27: Infusion Pumps, Global, Overall Revenue ($ mn), 2000 - 2012; Table 28: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2007-2012; Table 29: Spinal Surgery, Global, Overall Revenue ($ mn), 2007-2012; Table 30: Spinal non-fusion, US, Overall Revenue ($ mn), 2007 - 2012; Table 31: Aortic Stent Graft, US, Overall Revenue ($ mn), 2000-2012; Table 32: Glucose Monitoring, US, Overall Revenue ($ mn), 2000 - 2012; Table 33: Full Field Digital Mammography, Global, Overall Revenue ($ mn), 2000 - 2012; Table 34: Hospital Supplies, Global, Overall Revenue ($ mn), 2000 - 2012; Table 35: Arthroscopy, US, Overall Revenue ($ mn), 2000 - 2012; Table 36: Intra Ocular Lens , US, Overall Revenue ($ mn), 2000 - 2012; Table 37: Soft Contact Lens, US, Overall Revenue ($ mn), 2000 - 2012; Table 38: The US National Health Expenditures, 2006 ($ bn); Table 39: Number of persons without health insurance, US, 1997 - March, 2008; Table 40: Medical Equipment Financial Deals, January 1, 2008 - November 5. 2008; Table 41: Medical Equipment Financial Deals, by Market, January 1, 2008 - November 5. 2008; Table 42: Medical Equipment Acquisitions, by Market, January 1, 2008 - November 5. 2008
1.2 List of Figures: Figure 1: Cardiovascular, US, Diseases %, 2007; Figure 2: Orthopedic Devices , US, Overall Revenue ($ mn), 2000 - 2012; Figure 3: Medical Equipment, China, Overall Revenue ($ mn), 2000 - 2012; Figure 4: Medical Equipment, Russian Federation, Overall Revenue ($ mn), 2000-2012; Figure 5: Medical Equipment, Brazil, Overall Revenue ($ mn), 2000 - 2012; Figure 6: Medical Equipment, India, Overall Revenue ($ mn), 2000 - 2012; Figure 7: Medical Equipment, Taiwan, Overall Revenue ($ mn), 2000 - 2012; Figure 8: Medical Equipment, Republic of Korea, Overall Revenue ($ mn), 2000 - 2012; Figure 9: Medical Tourism, India, Overall Revenue ($ mn), 2002 - 2012; Figure 10: Healthcare IT, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 11: Healthcare IT, Revenue Breakup by Geography (%), 2007; Figure 12: PACS, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 13: PACS, Global, Company Share (%), 2007; Figure 14: Hospital Information Systems, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 15: Hospital Information Systems, Global, Company Share (%), 2007; Figure 16: Healthcare IT, India, Overall Revenue ($ mn), 2000 - 2012; Figure 17: Coronary Stent, US, Overall Revenue ($ mn), 2000 - 2007; Figure 18: Drug Eluting Stent, US, Overall Revenue ($ mn), 2007 - 2012; Figure 19: Drug Eluting Stent, US, Company Share (%), 2007; Figure 20: Hip Resurfacing, US, Company Share (%), October 2008; Figure 21: Hip Resurfacing, US, Overall Revenue ($ mn), 2006 - 2012; Figure 22: Home Healthcare Equipment, Global, Overall Revenue ($ mn), 2007-2012; Figure 23: Diabetes care devices, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 24: Glucose Monitoring and Insulin Delivery devices, Global, Overall Revenue ($ mn), 2000-2012; Figure 25: Diabetes Care Devices, Global, Company Share (%), 2007; Figure 26: Digital Signal Processing Hearing Aids, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 27: Digital Signal Processing Hearing Aids, Global, Company Share (%), 2007; Figure 28: Respiratory Devices , Global, Company Share (%), 2007; Figure 29: CPAP and Nebulizers, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 30: Drug Delivery Devices, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 31: Dry Powdered Inhalers, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 32: Needle Free Injections, Global, Overall Revenue ($ mn), 2007-2012; Figure 33: Infusion Pumps, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 34: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2007 - 2012; Figure 35: Spinal Surgery, Global, Overall Revenue ($ mn), 2007 - 2012; Figure 36: Spinal non-fusion, US, Overall Revenue ($ mn), 2007 - 2012; Figure 37: Aortic Stent Graft, US, Overall Revenue ($ mn), 2000-2012; Figure 38: Glucose Monitoring, US, Overall Revenue ($ mn), 2000 - 2012; Figure 39: Mammography equipment, Global, Companies, %, 2007; Figure 40: Full Field Digital Mammography, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 41: Hospital Supplies, Global, Overall Revenue ($ mn), 2000 - 2012; Figure 42: Cardiovascular Prosthetic Devices, Global, Companies, %, 2007; Figure 43: Arthroscopy, US, Overall Revenue ($ mn), 2000 - 2012; Figure 44: Intra Ocular Lens , US, Overall Revenue ($ mn), 2000 - 2012; Figure 45: Soft Contact Lens, US, Overall Revenue ($ mn), 2000 - 2012; Figure 46: Share price trends of leading medical equipment pure-plays, 2008; Figure 47: Share price trends of leading medical equipment pure-plays, January, 2005 - October, 2008; Figure 48: Global Medical Equipment Deal Landscape, 2008; Figure 49: Macro-environment Risk Susceptibility, Leading Medical Equipment Companies; Figure 50: Boston Scientific Corporation, Share Price ($), Adj Close*, January 02, 2008 - October 31, 2008; Figure 51: Genentech, Share Price ($), Adj Close*, July 18, 2008 - October 31, 2008; Figure 52: The US National Health Expenditures, Providers, %, 2006; Figure 53: Medical Equipment Financial Deals, January 1, 2008 - November 5. 2008; Figure 54: Medical Equipment Financial Deals, by Market, January 1, 2008 - November 5. 2008; Figure 55: Medical Equipment Acquisitions, by Market, January 1, 2008 - November 5. 2008; Figure 56: Electrophysiology Market, Global, Company Share, %, 2007; Figure 57: Electrophysiology Market, Global, Overall Revenue ($mn), 2000-2012; Figure 58: Cardiovascular Surgery & Cardiac Assist Devices Market, Global, Overall Revenue ($mn), 2007-2012; Figure 59: Global Markets Direct Methodology

Ordering and More Information

Price and Delivery Options

MindBranch has been the leading provider of industry and investment research from more than 550 independent research firms since 1992. With over 90,000 market research reports, MindBranch is your trusted source of competitive business intelligence.